202 related articles for article (PubMed ID: 12239150)
1. Long-term reversal of chronic anemia using a hypoxia-regulated erythropoietin gene therapy.
Binley K; Askham Z; Iqball S; Spearman H; Martin L; de Alwis M; Thrasher AJ; Ali RR; Maxwell PH; Kingsman S; Naylor S
Blood; 2002 Oct; 100(7):2406-13. PubMed ID: 12239150
[TBL] [Abstract][Full Text] [Related]
2. Long-term and stable correction of uremic anemia by intramuscular injection of plasmids containing hypoxia-regulated system of erythropoietin expression.
Sun J; Wang Y; Yang J; Du D; Li Z; Wei J; Yang A
Exp Mol Med; 2012 Nov; 44(11):674-83. PubMed ID: 22990115
[TBL] [Abstract][Full Text] [Related]
3. Delivery of erythropoietin by encapsulated myoblasts in a genetic model of severe anemia.
Rinsch C; Dupraz P; Schneider BL; Déglon N; Maxwell PH; Ratcliffe PJ; Aebischer P
Kidney Int; 2002 Oct; 62(4):1395-401. PubMed ID: 12234311
[TBL] [Abstract][Full Text] [Related]
4. Long-term erythropoietin expression in rodents and non-human primates following intramuscular injection of a replication-defective adenoviral vector.
Svensson EC; Black HB; Dugger DL; Tripathy SK; Goldwasser E; Hao Z; Chu L; Leiden JM
Hum Gene Ther; 1997 Oct; 8(15):1797-806. PubMed ID: 9358029
[TBL] [Abstract][Full Text] [Related]
5. Renal Anemia Model Mouse Established by Transgenic Rescue with an Erythropoietin Gene Lacking Kidney-Specific Regulatory Elements.
Hirano I; Suzuki N; Yamazaki S; Sekine H; Minegishi N; Shimizu R; Yamamoto M
Mol Cell Biol; 2017 Feb; 37(4):. PubMed ID: 27920250
[TBL] [Abstract][Full Text] [Related]
6. Identification of the renal erythropoietin-producing cells using transgenic mice.
Maxwell PH; Osmond MK; Pugh CW; Heryet A; Nicholls LG; Tan CC; Doe BG; Ferguson DJ; Johnson MH; Ratcliffe PJ
Kidney Int; 1993 Nov; 44(5):1149-62. PubMed ID: 8264149
[TBL] [Abstract][Full Text] [Related]
7. Controlled nonviral gene delivery and expression using stable neural stem cell line transfected with a hypoxia-inducible gene expression system.
Liu ML; Oh JS; An SS; Pennant WA; Kim HJ; Gwak SJ; Yoon DH; Kim KN; Lee M; Ha Y
J Gene Med; 2010 Dec; 12(12):990-1001. PubMed ID: 21157823
[TBL] [Abstract][Full Text] [Related]
8. Cerebral adaptations to chronic anemia in a model of erythropoietin-deficient mice exposed to hypoxia.
El Hasnaoui-Saadani R; Pichon A; Marchant D; Olivier P; Launay T; Quidu P; Beaudry M; Duvallet A; Richalet JP; Favret F
Am J Physiol Regul Integr Comp Physiol; 2009 Mar; 296(3):R801-11. PubMed ID: 19109375
[TBL] [Abstract][Full Text] [Related]
9. Continuous delivery of human and mouse erythropoietin in mice by genetically engineered polymer encapsulated myoblasts.
Régulier E; Schneider BL; Déglon N; Beuzard Y; Aebischer P
Gene Ther; 1998 Aug; 5(8):1014-22. PubMed ID: 10326023
[TBL] [Abstract][Full Text] [Related]
10. Gene therapy for renal anemia in mice with polycystic kidney using an adenovirus vector encoding the human erythropoietin gene.
Osada S; Ebihara I; Setoguchi Y; Takahashi H; Tomino Y; Koide H
Kidney Int; 1999 Apr; 55(4):1234-40. PubMed ID: 10200985
[TBL] [Abstract][Full Text] [Related]
11. Biological characterization of recombinant human erythropoietin.
Krumwieh D; Arnold I; Seiler FR
Behring Inst Mitt; 1988 Aug; (83):193-201. PubMed ID: 3240225
[TBL] [Abstract][Full Text] [Related]
12. Therapy of anemia in kidney failure, using plasmid encoding erythropoietin.
Richard-Fiardo P; Payen E; Chèvre R; Zuber J; Letrou-Bonneval E; Beuzard Y; Pitard B
Hum Gene Ther; 2008 Apr; 19(4):331-42. PubMed ID: 18341422
[TBL] [Abstract][Full Text] [Related]
13. A mouse model for an erythropoietin-deficiency anemia.
Zeigler BM; Vajdos J; Qin W; Loverro L; Niss K
Dis Model Mech; 2010; 3(11-12):763-72. PubMed ID: 20959632
[TBL] [Abstract][Full Text] [Related]
14. Expression of a homologously recombined erythopoietin-SV40 T antigen fusion gene in mouse liver: evidence for erythropoietin production by Ito cells.
Maxwell PH; Ferguson DJ; Osmond MK; Pugh CW; Heryet A; Doe BG; Johnson MH; Ratcliffe PJ
Blood; 1994 Sep; 84(6):1823-30. PubMed ID: 8080987
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy for long-term expression of erythropoietin in rats.
Osborne WR; Ramesh N; Lau S; Clowes MM; Dale DC; Clowes AW
Proc Natl Acad Sci U S A; 1995 Aug; 92(17):8055-8. PubMed ID: 7644537
[TBL] [Abstract][Full Text] [Related]
16. [Erythropoietin-beta in the treatment of anemia in patients with chronic renal insufficiency].
Dimković N
Med Pregl; 2001; 54(5-6):235-40. PubMed ID: 11759218
[TBL] [Abstract][Full Text] [Related]
17. A hypoxia-inducible gene expression system using erythropoietin 3' untranslated region for the gene therapy of rat spinal cord injury.
Choi BH; Ha Y; Ahn CH; Huang X; Kim JM; Park SR; Park H; Park HC; Kim SW; Lee M
Neurosci Lett; 2007 Jan; 412(2):118-22. PubMed ID: 17178192
[TBL] [Abstract][Full Text] [Related]
18. Regulated expression of erythropoietin from an AAV vector safely improves the anemia of beta-thalassemia in a mouse model.
Johnston J; Tazelaar J; Rivera VM; Clackson T; Gao GP; Wilson JM
Mol Ther; 2003 Apr; 7(4):493-7. PubMed ID: 12727112
[TBL] [Abstract][Full Text] [Related]
19. Isolation and characterization of renal erythropoietin-producing cells from genetically produced anemia mice.
Pan X; Suzuki N; Hirano I; Yamazaki S; Minegishi N; Yamamoto M
PLoS One; 2011; 6(10):e25839. PubMed ID: 22022454
[TBL] [Abstract][Full Text] [Related]
20. Characterisation of the ventilatory response to hypoxia in a model of transgenic anemic mice.
Macarlupú JL; Buvry A; Morel OE; León-Velarde F; Richalet JP; Favret F
Respir Physiol Neurobiol; 2006 Jan; 150(1):19-26. PubMed ID: 15878311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
